Pharmaceutical Industry

Page 89 of 100

Parkinson’s patients show improvement after taking cancer drug
Health

Parkinson’s patients show improvement after taking cancer drug

By
October 19, 2015
J. Michael Pearson, Chairman of the board and Chief Executive Officer of Valeant Pharmaceuticals International Inc., waits for the start of their annual general meeting in Laval, Quebec
Health

Valeant eases up on strategy to buy up ‘mispriced drugs’

By
October 19, 2015
J. Michael Pearson, Chairman of the board and Chief Executive Officer of Valeant Pharmaceuticals International Inc., waits for the start of their annual general meeting in Laval, Quebec
Health

News Correspondent

By Reuters and Coins2Day Editors
October 19, 2015
Hillary Clinton in the first Democratic presidential debate in Las Vegas on Oct. 13
Commentary

Clinton’s big pharma takedown plan has some serious issues

By Chris Ford and Bethany Cianciolo
October 16, 2015
Democratic Candidates Attend New Hampshire Democratic Party Convention
Leadership

Bernie Sanders rejects drug price-raising CEO’s donation: ‘We don’t want his stinkin’ money’

By
October 16, 2015
CNBC NEWS-- Pictured: Jeb Bush, former Governor of Florida and 2016 presidential election candidate, in an interview at the Parlor City Pub and Eatery in Cedar Rapids, Iowa on September 22, 2015 -- (Photo by: Mary Stevens/CNBC/NBCU Photo Bank)
Health

Jeb Bush’s health care plan would dismantle Obamacare

By
October 15, 2015
J. Michael Pearson, chief executive officer, Valeant Pharmaceuticals International Inc., speaks during the Bloomberg Economic Series: Canada 2015 in Toronto, Ontario Thursday May 21/2015. (Photo by Kevin Van Paassen/Bloomberg)
Health

Valeant under federal investigation for how it prices drugs

By
October 15, 2015
Johnson & Johnson Products Ahead Of Earnings
Health

Johnson & Johnson struggles to boost drug sales even as profits gain

By
October 13, 2015
Eli Lilly & Co's Zyprexa schizophrenia drug is pictured in a
Finance

Eli Lilly adds one more to roster of failed heart drugs, and it won’t be the last

By
October 12, 2015
General Views of Eli Lilly & Co.
Health

Why drug maker Eli Lilly’s stock price is down big today

By
October 12, 2015
Hedge fund manager Bill Ackman
Finance

The strange thing about Bill Ackman’s defense of Valeant’s drug prices

By
October 7, 2015
AmerisourceBergen pays $2.58 billion to buy PharMEDium
Health

AmerisourceBergen pays $2.58 billion to buy PharMEDium

By
October 6, 2015
Symbolic - biotechnology - genetic engineering
Health

TPP trade deal: Even more bad news for biotech industry

By
October 5, 2015
Japan Scenics
Health

This Japanese pufferfish could be the ultimate painkiller

By
September 30, 2015
Why drug price controversy is great news for this hedge fund manager
Finance

Why drug price controversy is great news for this hedge fund manager

By
September 30, 2015

Most Popular